These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 9425441

  • 1. Tumour immunotherapy using an adenoviral vector expressing a membrane-bound mutant of murine TNF alpha.
    Marr RA, Addison CL, Snider D, Muller WJ, Gauldie J, Graham FL.
    Gene Ther; 1997 Nov; 4(11):1181-8. PubMed ID: 9425441
    [Abstract] [Full Text] [Related]

  • 2. A p75 tumor necrosis factor receptor-specific mutant of murine tumor necrosis factor alpha expressed from an adenovirus vector induces an antitumor response with reduced toxicity.
    Marr RA, Hitt M, Gauldie J, Muller WJ, Graham FL.
    Cancer Gene Ther; 1999 Nov; 6(5):465-74. PubMed ID: 10505857
    [Abstract] [Full Text] [Related]

  • 3. Transgene expression of alpha tumor necrosis factor with mutations D142N and A144R under control of human telomerase reverse transcriptase promoter eradicates well-established tumors and induces long-term antitumor immunity.
    Xiang J, Munegowda MA, Deng Y.
    Cancer Gene Ther; 2009 May; 16(5):430-8. PubMed ID: 19096444
    [Abstract] [Full Text] [Related]

  • 4. [Gene transfer of murine Flt3 ligand mediated by adenoviral vector efficiently induces growth inhibition of murine liver cancer].
    Yang Q, Yang G, Wei L, Jia F, Wu M, Guo Y.
    Zhonghua Yi Xue Za Zhi; 2002 Jun 10; 82(11):775-9. PubMed ID: 12126551
    [Abstract] [Full Text] [Related]

  • 5. Respective roles of TNF-alpha and IL-6 in the immune response-elicited by adenovirus-mediated gene transfer in mice.
    Benihoud K, Esselin S, Descamps D, Jullienne B, Salone B, Bobé P, Bonardelle D, Connault E, Opolon P, Saggio I, Perricaudet M.
    Gene Ther; 2007 Mar 10; 14(6):533-44. PubMed ID: 17109009
    [Abstract] [Full Text] [Related]

  • 6. Immunotherapy of established tumors in mice by intratumoral injection of an adenovirus vector harboring the human IL-2 cDNA: induction of CD8(+) T-cell immunity and NK activity.
    Slos P, De Meyer M, Leroy P, Rousseau C, Acres B.
    Cancer Gene Ther; 2001 May 10; 8(5):321-32. PubMed ID: 11477452
    [Abstract] [Full Text] [Related]

  • 7. Combinational immunotherapy for established tumors with engineered tumor vaccines and adenovirus-mediated gene transfer.
    Xiang J, Chen Y, Moyana T.
    Cancer Gene Ther; 2000 Jul 10; 7(7):1023-33. PubMed ID: 10917205
    [Abstract] [Full Text] [Related]

  • 8. Assessment of a combined, adenovirus-mediated oncolytic and immunostimulatory tumor therapy.
    Bernt KM, Ni S, Tieu AT, Lieber A.
    Cancer Res; 2005 May 15; 65(10):4343-52. PubMed ID: 15899826
    [Abstract] [Full Text] [Related]

  • 9. Cancer gene therapy using a novel secretable trimeric TRAIL.
    Kim CY, Jeong M, Mushiake H, Kim BM, Kim WB, Ko JP, Kim MH, Kim M, Kim TH, Robbins PD, Billiar TR, Seol DW.
    Gene Ther; 2006 Feb 15; 13(4):330-8. PubMed ID: 16195699
    [Abstract] [Full Text] [Related]

  • 10. Conditionally replicative adenovirus vector carrying TRAIL gene for enhanced oncolysis of human hepatocellular carcinoma.
    Ye X, Lu Q, Zhao Y, Ren Z, Ren XW, Qiu QH, Tong Y, Liang M, Hu F, Chen HZ.
    Int J Mol Med; 2005 Dec 15; 16(6):1179-84. PubMed ID: 16273304
    [Abstract] [Full Text] [Related]

  • 11. Functional and molecular characterization of tumor-infiltrating lymphocytes transduced with tumor necrosis factor-alpha cDNA for the gene therapy of cancer in humans.
    Hwu P, Yannelli J, Kriegler M, Anderson WF, Perez C, Chiang Y, Schwarz S, Cowherd R, Delgado C, Mulé J.
    J Immunol; 1993 May 01; 150(9):4104-15. PubMed ID: 8473752
    [Abstract] [Full Text] [Related]

  • 12. Intratumoral vaccination of adenoviruses expressing fusion protein RM4/tumor necrosis factor (TNF)-alpha induces significant tumor regression.
    Wright P, Zheng C, Moyana T, Xiang J.
    Cancer Gene Ther; 1998 May 01; 5(6):371-9. PubMed ID: 9917092
    [Abstract] [Full Text] [Related]

  • 13. Blockade of TNF-alpha decreases both inflammation and efficacy of intrapulmonary Ad.IFNbeta immunotherapy in an orthotopic model of bronchogenic lung cancer.
    Wilderman MJ, Kim S, Gillespie CT, Sun J, Kapoor V, Vachani A, Sterman DH, Kaiser LR, Albelda SM.
    Mol Ther; 2006 May 01; 13(5):910-7. PubMed ID: 16488193
    [Abstract] [Full Text] [Related]

  • 14. Suppressing orthotopic pancreatic tumor growth with a fiber-modified adenovector expressing the TRAIL gene from the human telomerase reverse transcriptase promoter.
    Jacob D, Davis J, Zhu H, Zhang L, Teraishi F, Wu S, Marini FC, Fang B.
    Clin Cancer Res; 2004 May 15; 10(10):3535-41. PubMed ID: 15161713
    [Abstract] [Full Text] [Related]

  • 15. Development of an adenovirus vector with tetracycline-regulatable human tumor necrosis factor alpha gene expression.
    Hu SX, Ji W, Zhou Y, Logothetis C, Xu HJ.
    Cancer Res; 1997 Aug 15; 57(16):3339-43. PubMed ID: 9269991
    [Abstract] [Full Text] [Related]

  • 16. A tumor-specific conditionally replicative adenovirus vector expressing TRAIL for gene therapy of hepatocellular carcinoma.
    Ren XW, Liang M, Meng X, Ye X, Ma H, Zhao Y, Guo J, Cai N, Chen HZ, Ye SL, Hu F.
    Cancer Gene Ther; 2006 Feb 15; 13(2):159-68. PubMed ID: 16082383
    [Abstract] [Full Text] [Related]

  • 17. Mechanisms involved in development of resistance to adenovirus-mediated proapoptotic gene therapy in DLD1 human colon cancer cell line.
    Zhang L, Gu J, Lin T, Huang X, Roth JA, Fang B.
    Gene Ther; 2002 Sep 15; 9(18):1262-70. PubMed ID: 12215894
    [Abstract] [Full Text] [Related]

  • 18. Adenoviral TNF-alpha gene therapy and radiation damage tumor vasculature in a human malignant glioma xenograft.
    Staba MJ, Mauceri HJ, Kufe DW, Hallahan DE, Weichselbaum RR.
    Gene Ther; 1998 Mar 15; 5(3):293-300. PubMed ID: 9614548
    [Abstract] [Full Text] [Related]

  • 19. Expression of an exogenous tumor necrosis factor (TNF) gene in TNF-sensitive cell lines confers resistance to TNF-mediated cell lysis.
    Vanhaesebroeck B, Decoster E, Van Ostade X, Van Bladel S, Lenaerts A, Van Roy F, Fiers W.
    J Immunol; 1992 May 01; 148(9):2785-94. PubMed ID: 1374099
    [Abstract] [Full Text] [Related]

  • 20. Comparison of high-capacity and first-generation adenoviral vector gene delivery to murine muscle in utero.
    Bilbao R, Reay DP, Wu E, Zheng H, Biermann V, Kochanek S, Clemens PR.
    Gene Ther; 2005 Jan 01; 12(1):39-47. PubMed ID: 15483668
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.